AstraZeneca shares slump after Phase 3 lung cancer drug study By: MarketWatch July 03, 2023 at 08:35 AM EDT AstraZeneca shares fell Monday after a late-stage study on a lung cancer drug disappointed investors. Read More >> Related Stocks: Astrazeneca Plc ADR
